Información básica

Nombre: Bryan Sisk
Título: Assistant Professor
Institución: Washington University School of Medicine in St. Louis
Disciplina: Medicamento
Años de experiencia: 6

Investigación

Enfoque metodológico primario de la investigación:

• Oncología
• Relación paciente-proveedor

Enfoque de la investigación en comunicación y salud:

• Codiseño
• Delphi y los métodos de búsqueda de consenso
• Métodos cualitativos
• Revisión sistemática de la literatura.

Descripción

Tres palabras clave que describen experiencia e interés:

1. rare disease
2. cancer
3. pediatrics

Descripción del campo de especialización, intereses principales y temas de consulta:

Dr. Sisk’s research focuses on communication and the role of evolving technologies in the care of patients with cancer and rare diseases. His team developed the first functional model of communication in pediatric oncology, and have since adapted this model to other serious pediatric illnesses. His team also developed the first validated measure of these communication functions in pediatric oncology. His current studies are exploring how to best leverage online patient portals to improve communication and support medical management of children with serious illnesses. He is also leading studies that aim to retrain large language model (LLM) powered chatbots to provide high-quality information to families affected by rare diseases. His clinical expertise is vascular anomalies, and he serves as co-director of both the Vascular Anomalies Center and HHT Center of Excellence at Washington University in St. Louis, as well as Membership Chair for the Consortium of Investigators for Vascular Anomalies.

Breve biografía:

BRYAN SISK is an assistant professor in Department of Pediatrics’ Division of Pediatric Hematology and Oncology at Washington University School of Medicine, with a joint appointment in the Bioethics Research Center in the Department of Medicine. Sisk completed his MD at the Cleveland Clinic Lerner College of Medicine at Case Western Reserve University, and completed his subsequent clinical training at St. Louis Children’s Hospital and Washington University. Dr. Sisk also completed the Mentored Training Program in Clinical Investigation (MTPCI) and earned a Master of Science in Clinical Investigation (MSCI) from Washington University School of Medicine.

Dr. Sisk’s research focuses on communication and the role of evolving technologies in the care of patients with cancer and rare diseases. His team developed the first functional model of communication in pediatric oncology, and have since adapted this model to other serious pediatric illnesses. His team also developed the first validated measure of these communication functions in pediatric oncology. His current studies are exploring how to best leverage online patient portals to improve communication and support medical management of children with serious illnesses. He is also leading studies that aim to retrain large language model (LLM) powered chatbots to provide high-quality information to families affected by rare diseases. His clinical expertise is vascular anomalies, and he serves as co-director of both the Vascular Anomalies Center and HHT Center of Excellence at Washington University in St. Louis, as well as Membership Chair for the Consortium of Investigators for Vascular Anomalies.